75 related articles for article (PubMed ID: 22821478)
1. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells.
Xie F; Dong H; Zhang H
Front Immunol; 2021; 12():783370. PubMed ID: 34880876
[TBL] [Abstract][Full Text] [Related]
3. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
[TBL] [Abstract][Full Text] [Related]
4. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
[TBL] [Abstract][Full Text] [Related]
5. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
Huang YT; Li FF; Ke C; Li Z; Li ZT; Zou XF; Zheng XX; Chen YP; Zhang H
J Transl Med; 2013 Oct; 11():245. PubMed ID: 24090193
[TBL] [Abstract][Full Text] [Related]
6. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Hou J; Zhang H; Liu J; Zhao Z; Wang J; Lu Z; Hu B; Zhou J; Zhao Z; Feng M; Zhang H; Shen B; Huang X; Sun B; Smyth MJ; He C; Xia Q
Mol Cancer; 2019 Nov; 18(1):163. PubMed ID: 31735169
[TBL] [Abstract][Full Text] [Related]
7. The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications.
Hou J; Zhang H; Sun B; Karin M
J Hepatol; 2020 Jan; 72(1):167-182. PubMed ID: 31449859
[TBL] [Abstract][Full Text] [Related]
8. Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-κB activation.
Jiang R; Chen D; Hou J; Tan Z; Wang Y; Huang X; Wang X; Sun B
J Immunol; 2014 Nov; 193(10):5161-70. PubMed ID: 25339662
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
Chaturantabut S; Shwartz A; Evason KJ; Cox AG; Labella K; Schepers AG; Yang S; Acuña M; Houvras Y; Mancio-Silva L; Romano S; Gorelick DA; Cohen DE; Zon LI; Bhatia SN; North TE; Goessling W
Gastroenterology; 2019 May; 156(6):1788-1804.e13. PubMed ID: 30641053
[TBL] [Abstract][Full Text] [Related]
10. Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients.
Mestareehi A; Abu-Farsakh N
ACS Omega; 2024 Mar; 9(9):10299-10331. PubMed ID: 38463290
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.
Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q
Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570
[TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.
Li R; Liu X; Huang X; Zhang D; Chen Z; Zhang J; Bai R; Zhang S; Zhao H; Xu Z; Zeng L; Zhuang L; Wen S; Wu S; Li M; Zuo Z; Lin J; Lin D; Zheng J
Gut; 2024 Feb; 73(3):470-484. PubMed ID: 38050068
[TBL] [Abstract][Full Text] [Related]
13. Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management.
Yang F; Wu Y; Hockey R; ; Doust J; Mishra GD; Montgomery GW; Mortlock S
Cell Rep Med; 2023 Nov; 4(11):101250. PubMed ID: 37909040
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2.
Xu Y; Zhu Y; Wu Z; Li S; Shao M; Tao Q; Xu Q; Chen Y; Shu Y; Chen M; Zhou Y; Shi Y
BMC Cancer; 2023 Sep; 23(1):906. PubMed ID: 37752418
[TBL] [Abstract][Full Text] [Related]
15. Novel hybrid motifs of 4-nitroimidazole-piperazinyl tagged 1,2,3-triazoles: Synthesis, crystal structure, anticancer evaluations, and molecular docking study.
Saber SW; Al-Qawasmeh RA; Abu-Qatouseh L; Shtaiwi A; Khanfar MA; Al-Soud YA
Heliyon; 2023 Sep; 9(9):e19327. PubMed ID: 37681149
[TBL] [Abstract][Full Text] [Related]
16. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma.
Nevola R; Tortorella G; Rosato V; Rinaldi L; Imbriani S; Perillo P; Mastrocinque D; La Montagna M; Russo A; Di Lorenzo G; Alfano M; Rocco M; Ricozzi C; Gjeloshi K; Sasso FC; Marfella R; Marrone A; Kondili LA; Esposito N; Claar E; Cozzolino D
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508414
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma.
Wei R; Feng OQ; Hui YZ; Huang X; Ping LS
Biosci Rep; 2023 Jul; 43(7):. PubMed ID: 37133437
[TBL] [Abstract][Full Text] [Related]
18. Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma.
Lin Z; Zhang J; Liu B; Hong Z; Chen Z; Huang X
Mediators Inflamm; 2023; 2023():5248897. PubMed ID: 36816740
[TBL] [Abstract][Full Text] [Related]
19. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review).
Chen YL; Hsieh CC; Chu PM; Chen JY; Huang YC; Chen CY
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36660927
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Proteomic Strategy to Identify SHP2 Substrates.
Zhu P; Wu X; Zhang RY; Hsu CC; Zhang ZY; Tao WA
J Proteome Res; 2022 Oct; 21(10):2515-2525. PubMed ID: 36103635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
